Management of Symptomatic Cholelithiasis
Management of Symptomatic Cholelithiasis
Abstract
Background: Symptomatic cholelithiasis is a common surgical disease and accounts for half of the over one mil-
lion cholecystectomies performed in the USA annually. Despite its prevalence, only one prior systematic review has
examined the evidence around treatment strategies and it contained a narrow scope. The goal of this systematic
review was to analyze the clinical effectiveness of treatment options for symptomatic cholelithiasis, including surgery,
non-surgical therapies, and ED pain management strategies.
Methods: Literature search was performed from January 2000 through June 2020, and a narrative analysis was
per- formed as studies were heterogeneous.
Results: We identified 12 publications reporting on 10 trials (9 randomized controlled trials and 1 observational
study) comparing treatment methods. The studies assessed surgery, observation, lithotripsy, ursodeoxycholic acid,
electro-acupuncture, and pain-management strategies in the emergency department. Only one compared surgery to
observation.
Conclusion: This work presents the existing data and underscores the current gap in knowledge regarding treat-
ment for patients with symptomatic cholelithiasis. We use these results to suggest how future trials may guide
comparisons between the timing of surgery and watchful waiting to create a set of standardized guidelines. Provid-
ing appropriate and timely treatment for symptomatic cholelithiasis is important to streamline care for a costly and
prevalent disease.
Trial registration: PROSPERO Protocol Number: CRD42020153153
Keywords: Symptomatic cholelithiasis, biliary colic, treatment, management, cholecystectomy, UDCA
© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to
the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The
images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use
is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright
holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain
Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated in a credit line to the data.
Shenoy et al. Systematic Reviews (2022) 11:267 Page 2 of
9
Fig. 1 Literature flow. *PubMed = 2575, Cochrane Trials 909, Cochrane Review 25, Embase 2838
Table 1 Characteristics of included studies by comparative arms: surgery, non-surgical, and ED pain management
Author, year Comparison Number of sites Study design Sample size Follow-up time
Vetrhus, 2002 [16], Vetrhus 2004 Surgery vs. observation Multiple Randomized 137 5 years [15, 16]
[15], and Schmidt, 2011 [19]a 14 years [19]
Ahmed, 2000 [14] Surgery vs. lithotripsy Single Randomized 144 5 years
Salman, 2005 [17] Urgent vs. elective surgery Single Randomized 75 Not specified
Anwar, 2008 [18]b Urgent vs. elective surgery Single Observational 96 Not specified
Van Dijk, 2019 [20]c Surgeon discretion vs. pre-specified criteria Multiple Randomized 1067 1 year
Petroni, 2001 [21] UDCAd vs. UDCA + bile salts Multiple Randomized 158 2 years
Venneman, 2006 [22] UDCA vs. placebo Multiple Randomized 177 Variede
Wong, 2019 [25] Electro-acupuncture vs. observation n/a Randomized 46 Not specified
Malesci, 2003 [23] ED pain managemente Single Randomized 14 48h
Antevil, 2004 [24] ED pain managementf Single Randomized 38 20 min
a
Studies looked at same population, examined different outcomes at different timepoints
b
Anwar, 2008 defined urgent cholecystectomy as early/same-day
c
Surgeon discretion defined as operation based on standard care left to the discretion of the surgeon; restrictive strategy used the fulfillment of five pre-specified
criteria as indication for operation
d
UDCA Ursodeoxycholic acid
e
Followed until they received surgery or for 12 months from start of treatment if refused surgery
e
Hyoscine-N-butyl bromide vs. Loxiglumide
f
Glycopyrrolate vs. placebo
Shenoy et al. Systematic Reviews (2022) 11:267 Page 4 of
9
work provides a current, comprehensive analysis of treat- Received: 20 December 2021 Accepted: 8 November 2022
ment strategies for symptomatic cholelithiasis.
Based on our findings, medical or alternate therapies
for symptomatic cholelithiasis such as UDCA, lithotripsy,
or electro-acupuncture as compared to surgery or References
watch- ful waiting have not been well studied. Studies 1. Gurusamy KS, Koti R, Fusai G, Davidson BR. Early versus delayed lapa-
roscopic cholecystectomy for uncomplicated biliary colic. Cochrane
compar- ing the timing of surgery or watchful waiting at
Database Syst Rev. 2013;(6):Cd007196. https://doi.org/10.1002/14651858.
particular points in patient’s disease process are CD007196.pub3.
warranted to deter- mine optimal management and 2. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithi-
asis and cancer. Gut Liver. 2012;6(2):172–87. https://doi.org/10.5009/gnl.
create a set of stand- ardized guidelines to guide 2012.6.2.172.
clinicians when counseling patients. Providing 3. Attili AF, de Santis A, Capri R, Repice AM, Maselli S, Group G. The
appropriate and timely treatment for symptomatic natural history of gallstones: The GREPCO experience. Hepatology.
1995;21(3):656–60. https://doi.org/10.1002/hep.1840210309.
cholelithiasis is important to streamline care for a 4. McSherry CK, Ferstenberg H, Calhoun WF, Lahman E, Virshup M. The
costly and prevalent disease. natural history of diagnosed gallstone disease in symptomatic and
asymptomatic patients. Ann Surg. Jul 1985;202(1):59-63. doi:https://doi.
org/10.1097/00000658-198507000-00009
Supplementary Information 5. Friedman GD. Natural history of asymptomatic and symptomatic gall-
The online version contains supplementary material available at https://doi. stones. Am J Surg. 1993;165(4):399–404. https://doi.org/10.1016/S0002-
org/10.1186/s13643-022-02135-8. 9610(05)80930-4.
6. Gurusamy KS, Davidson C, Gluud C, Davidson BR. Early versus delayed
Additional file 1: Supplementary material 1. Search strategies. laparoscopic cholecystectomy for people with acute cholecystitis.
Cochrane Database Syst Rev. 2013;(6). https://doi.org/10.1002/14651858.
Additional file 2: Supplementary material 2. Data extraction tables. CD005440.pub3.
Additional file 3: Supplementary material 3. Risk of bias for rand- 7. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal
omized controlled trials and observational studies. and liver diseases, 2006. Am J Gastroenterol. 2006;101(9):2128–38. https://
doi.org/10.1111/j.1572-0241.2006.00723.x.
8. Tsui C, Klein R, Garabrant M. Minimally invasive surgery: national trends
Acknowledgements in adoption and future directions for hospital strategy. Surg
We have no additional acknowledgements. Endosc. 2013;27(7):2253–7.
https://doi.org/10.1007/s00464-013-2973-9.
Authors’ contributions 9. Glasgow RE, Cho M, Hutter MM, Mulvihill SJ. The spectrum and cost of
All authors substantially contributed to conception, design, acquisition of complicated gallstone disease in California. Arch Surg. 2000;135(9):1021–
data, and interpretation of data. RS, PK, MDV, and JH contributed to data 5. https://doi.org/10.1001/archsurg.135.9.1021.
analysis. RS, MR, and MMG drafted the manuscript. All authors critically revised 10. Altieri MS, Yang J, Zhu C, et al. What happens to biliary colic patients
the manuscript for important intellectual content and gave final approval in New York State? 10-year follow-up from emergency department
for the version to be published. visits. Surg Endosc. 2018;32(4):2058–66. https://doi.org/10.1007/
s00464-017-5902-5.
Funding 11. Portincasa P, Di Ciaula A, Wang HH, Moschetta A, Wang DQ.
Dr. Rivfka Shenoy is supposed by the VA Office of Academic Affiliations Medicinal treatments of cholesterol gallstones: old, current and new
through the VA/National Clinician Scholars Program. Funding was provided by perspectives. Curr Med Chem. 2009;16(12):1531–42.
the VA Quality Enhancement Research Initiative. The funders of the study had https://doi.org/10.2174/09298 6709787909631.
no role in design and conduct of the study; collection, management, analysis, 12. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s
and interpretation of the data; and preparation, review, or approval of the tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
manuscript or the decision to submit for publication. https://doi.org/10.1136/bmj.d5928.
13. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing
Availability of data and materials risk of bias in non-randomised studies of interventions. BMJ.
The datasets generated and analyzed during the current study are available in 2016;355:i4919. https://doi.org/10.1136/bmj.i4919.
Supplementary material 2. The articles used to generate these evidence 14. Ahmed R, Freeman JV, Ross B, Kohler B, Nicholl JP, Johnson AG. Long term
tables are available in the PubMed, Embase, or Cochrane repository. response to gallstone treatment - problems and surprises. Eur J Surg.
2000;166(6):447–54.
15. Vetrhus M, Søreide O, Eide GE, Solhaug JH, Nesvik I, Søndenaa K. Pain
Declarations and quality of life in patients with symptomatic, non-complicated
gallblad- der stones: results of a randomized controlled trial. Clinical
Competing interests Trial; Journal Article; Randomized Controlled Trial; Research Support,
Dr. Rivfka Shenoy was supported by the VA Office of Academic Non-U.S. Gov’t. Scand J Gastroenterol. 2004;39(3):270–6.
Affiliations through the VA/National Clinician Scholars Program while https://doi.org/10.1080/00365 520310008502.
working on this study. The other authors declare that they have no 16. Vetrhus M, Søreide O, Solhaug JH, Nesvik I, Søndenaa K. Symptomatic,
competing interests. non-complicated gallbladder stone disease. Operation or observation? A
randomized clinical study. Scand J Gastroenterol. 2002;37(7):834–9.
Author details 17. Salman B, Yüksel O, Irkörücü O, et al. Urgent laparoscopic cholecystec-
1
Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, tomy is the best management for biliary colic. A prospective randomized
CA, USA. 2Veterans Health Administration, Greater Los Angeles Healthcare study of 75 cases. Dig Surg. 2005;22(1-2):95–9. https://doi.org/10.1159/
System, Los Angeles, CA, USA. 3National Clinician Scholars Program, UCLA, Los 000085300.
Angeles, CA, USA. 4Department of Surgery, Los Angeles County Harbor-UCLA 18. Anwar HA, Ahmed QA, Bradpiece HA. Removing symptomatic
Medical Center, Los Angeles, CA, USA. 5Louise M. Darling Biomedical Library, gallstones at the their first emergency presentation. Ann Royal College
UCLA Library, University of California, Los Angeles, CA, USA. 6Rand Corpora- Surgeons England. 2008;90(5):394–7.
tion, Santa Monica, CA, USA. 7Olive View-UCLA Medical Center, Sylmar, CA, https://doi.org/10.1308/003588408X301037.
USA. 19. Schmidt M, Søndenaa K, Vetrhus M, Berhane T, Eide GE. A randomized
controlled study of uncomplicated gallstone disease with a
14-year
Shenoy et al. Systematic Reviews (2022) 11:267 Page 9 of
9
follow-up showed that operation was the preferred treatment. Dig Surg.
2011;28(4):270–6. https://doi.org/10.1159/000329464.
20. van Dijk AH, Wennmacker SZ, de Reuver PR, et al. Restrictive strategy
versus usual care for cholecystectomy in patients with gallstones and
abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-
inferiority trial. Lancet. 2019;393(10188):2322–30.
https://doi.org/10.1016/ S0140-6736(19)30941-9.
21. Petroni ML, Jazrawi RP, Pazzi P, et al. Ursodeoxycholic acid alone or
with chenodeoxycholic acid for dissolution of cholesterol gallstones: a
randomized multicentre trial. The British-Italian Gallstone Study
group.
Clinical Trial; Journal Article; Multicenter Study; Randomized Con-
trolled Trial; Research Support, Non-U.S. Gov’t. Aliment Pharmacol Ther.
2001;15(1):123–8. https://doi.org/10.1046/j.1365-2036.2001.00853.x.
22. Venneman NG, Besselink MGH, Keulemans YCA, et al. Ursodeoxycholic
acid exerts no beneficial effect in patients with symptomatic gallstones
awaiting cholecystectomy. Hepatology. 2006;43(6):1276–83. https://doi.
org/10.1002/hep.21182.
23. Malesci A, Pezzilli R, D’Amato M, Rovati L. CCK-1 receptor blockade
for treatment of biliary colic: a pilot study. Aliment Pharmacol Ther.
2003;18(3):333–7. https://doi.org/10.1046/j.1365-2036.2003.01688.x.
24. Antevil JL, Buckley RG, Johnson AS, Woolf AM, Thoman DS,
Riffenburgh RH. Treatment of suspected symptomatic cholelithiasis
with glycopyr- rolate: a prospective, randomized clinical trial. Clinical Trial;
Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov’t,
Non-P.H.S. Ann Emerg Med. 2005;45(2):172–6.
https://doi.org/10.1016/j.annemergmed. 2004.06.017.
25. Wong W, Wu J, Sun W, et al. A randomized, single-blind, controlled
trial of electro-acupuncture for the treatment of symptomatic gallstone
dis- eases. Adv Integrative Med. 2019;6:S50.
https://doi.org/10.1016/j.aimed. 2019.03.148.
26. Festi D, Reggiani ML, Attili AF, et al. Natural history of gallstone
disease: expectant management or active treatment? Results from a
population- based cohort study. J Gastroenterol Hepatol.
2010;25(4):719–24. https:// doi.org/10.1111/j.1440-1746.2009.06146.x.
27. Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall
DH, et al. A controlled trial of arthroscopic surgery for osteoarthritis
of the knee. N Engl J Med. 2002;347(2):81–8.
https://doi.org/10.1056/NEJMo a013259.
28. Lawrentschuk N, Hewitt PM, Pritchard MG. Elective laparoscopic chol-
ecystectomy: Implications of prolonged waiting times for surgery. ANZ
J Surg. 2003;73(11):890–3. https://doi.org/10.1046/j.1445-2197.2003.
02826.x.
29. Mullen MG, Michaels AD, Mehaffey JH, et al. Risk associated with com-
plications and mortality after urgent surgery vs elective and emergency
surgery: implications for defining “quality” and reporting outcomes for
urgent surgery. JAMA Surg. 2017;152(8):768–74. https://doi.org/10.1001/
jamasurg.2017.0918.
30. Lau R, Vair BA, Porter GA. Factors influencing waiting times for elective
laparoscopic cholecystectomy. Can J Surg. 2007;50(1):34–8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
biomedcentral.com/submissions